Theriva Biologics, Inc. (TOVX)

0.2451 -0.01 (-2.93%) USD  |  NYAM  |  Aug 28, 16:00
0.2468 0.00 (0.00%) After-Hours: 20:00
More

Theriva Biologics Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for TOVX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Current Fiscal Year Data

View and export this data back to 2024. Start Trial.
Date Value
August 12, 2026 --
August 11, 2026 --
May 06, 2026 --
March 31, 2026 --
March 24, 2026 --
November 13, 2025 --
Date Value
May 08, 2025 --
March 11, 2025 --
November 12, 2024 --
August 13, 2024 --
March 26, 2024 --

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

View Revenue Estimates for Current Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Fiscal Year Benchmarks

View Revenue Estimates for Current Fiscal Year Benchmarks
Start Trial
Ironwood Pharmaceuticals, Inc. Upgrade
Nkarta, Inc. Upgrade
Unicycive Therapeutics, Inc. Upgrade
OnKure Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade

Revenue Estimates for Current Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade